Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03060525 · ClinicalTrials.gov registry record · NA

Deaf Weight Wise 2.0: A Healthy Lifestyle Intervention With Deaf Adults Who Are Overweight or Obese

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
76
Enrollment target

NCT03060525 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 76 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03060525, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target

Study Summary

The purpose of the Deaf Weight Wise 2.0 (DWW 2.0) study is to test an evidence-based, comprehensive program to modify obesity-related health behaviors with Deaf people ages 21 to 70 who use American Sign Language (ASL) as their primary language. Participants will be randomized to one of four arms: immediate intervention vs. intervention delayed one year, and in-person group intervention vs. individual intervention delivered via videophone. The investigators' primary hypothesis is that participants in the immediate DWW 2.0 intervention will increase their physical activity and reduce their caloric intake and body weight compared with those in the delayed intervention group (no intervention yet).

Interventions

  • BEHAVIORAL Deaf Weight Wise 2.0

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2017-01-25
Est. Completion 2019-08-29
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT03060525

The ClinicalTrials.gov registry entry for NCT03060525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Deaf Weight Wise 2.0 is the first listed.

NCT03060525 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03060525 about?

NCT03060525 is a clinical study titled "Deaf Weight Wise 2.0: A Healthy Lifestyle Intervention With Deaf Adults Who Are Overweight or Obese". The purpose of the Deaf Weight Wise 2.0 (DWW 2.0) study is to test an evidence-based, comprehensive program to modify obesity-related health behaviors with Deaf people ages 21 to 70 who use American Sign Language (ASL) as their primary language. Participants will be randomized to one of four arms: i...

What is the current status of trial NCT03060525?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2017-01-25. Estimated completion is 2019-08-29.

What interventions are being tested in trial NCT03060525?

The interventions under investigation include: Deaf Weight Wise 2.0 (BEHAVIORAL).

Who is sponsoring clinical trial NCT03060525?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.